Literature DB >> 9603121

Systemic corticosteroids decrease the effectiveness of talc pleurodesis.

C Xie1, L R Teixeira, J P McGovern, R W Light.   

Abstract

Corticosteroids can inhibit the inflammatory process and the formation of fibrosis. The purpose of this study was to determine whether the concurrent use of steroids at the time of talc-slurry pleurodesis would influence the development of the pleurodesis. One group of rabbits received an intrapleural injection of talc (400 mg/kg) and an intramuscular injection of triamcinolone (0.8 mg/kg) 1 d before talc instillation and weekly thereafter, whereas a control group received only talc. Ten rabbits in each group were killed at 6 h and at 1, 2, 4, 7, 14, and 28 d after instillation. The mean volume of pleural fluid was significantly lower in the group receiving corticosteroids at 6 h through 4 d after talc slurry than in the other groups. The degree of pleural adhesion was significantly smaller in the group receiving corticosteroids from Day 2 through Day 28. At Day 28, all 10 rabbits that received talc only had a pleurodesis score of 3 or 4, whereas only four of the 10 rabbits that also received steroids had a pleurodesis score of 3 or 4. This study shows that the use of corticosteroids at the time of talc-slurry pleurodesis markedly decreases the inflammatory reaction to the talc, and essentially prevents a pleurodesis from developing.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9603121     DOI: 10.1164/ajrccm.157.5.9708032

Source DB:  PubMed          Journal:  Am J Respir Crit Care Med        ISSN: 1073-449X            Impact factor:   21.405


  9 in total

1.  BTS guidelines for the management of malignant pleural effusions.

Authors:  G Antunes; E Neville; J Duffy; N Ali
Journal:  Thorax       Date:  2003-05       Impact factor: 9.139

Review 2.  Pleural effusion.

Authors:  A R Medford; A Medford; N Maskell
Journal:  Postgrad Med J       Date:  2005-11       Impact factor: 2.401

3.  Transforming growth factor beta2 induced pleurodesis is not inhibited by corticosteroids.

Authors:  Y C Lee; C J Devin; L R Teixeira; J T Rogers; P J Thompson; K B Lane; R W Light
Journal:  Thorax       Date:  2001-08       Impact factor: 9.139

Review 4.  Malignant pleural effusions: appropriate treatment approaches.

Authors:  Yener Aydin; Atila Turkyilmaz; Yavuz Selim Intepe; Atilla Eroglu
Journal:  Eurasian J Med       Date:  2009-12

5.  Impact of Factors Secreted by Tumor Cells on Response of Pleural Mesothelial Cells to Different Sclerosing Agents in an In Vitro Model.

Authors:  Michał Mierzejewski; Magdalena Paplińska-Goryca; Rafał Krenke
Journal:  Med Sci Monit       Date:  2022-05-10

6.  Non-steroid anti-inflammatory drugs reduce the efficacy of autologous blood pleurodesis.

Authors:  Serhat Yalçınkaya; Ulviye Yalçınkaya
Journal:  Turk Gogus Kalp Damar Cerrahisi Derg       Date:  2019-06-05       Impact factor: 0.332

Review 7.  Chemical pleurodesis - a review of mechanisms involved in pleural space obliteration.

Authors:  Michal Mierzejewski; Piotr Korczynski; Rafal Krenke; Julius P Janssen
Journal:  Respir Res       Date:  2019-11-07

8.  A mechanism for improved talc pleurodesis via foam delivery.

Authors:  T A Lima; R A Coler; G W Laub; S Sexton; L Curtin; K M Laub; N J Alvarez
Journal:  Drug Deliv       Date:  2021-12       Impact factor: 6.819

9.  Effectiveness and safety of iodopovidone in an experimental pleurodesis model.

Authors:  Lisete R Teixeira; Francisco S Vargas; Juliana Puka; Milena M P Acencio; Leila Antonangelo; Ricardo M Terra; Francisco M Damico; Fabio G Pitta; Evaldo Marchi
Journal:  Clinics (Sao Paulo)       Date:  2013-04       Impact factor: 2.365

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.